Evidence map›Paper›PMID 25076852›Full record

ArticleInternational journal of medical sciences2014

Wnt signaling as a possible promoting factor of cell differentiation in pleomorphic adenomas.

Yukiko Okuda, Keisuke Nakano, Koji Suzuki, Yoshihiko Sugita, Katsutoshi Kubo, Hatsuhiko Maeda, Norimasa Okafuji, Hiromasa Hasegawa, Toshiyuki Kawakami

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Unique Cohorts of Salivary Gland Cancer Cells as anJournal of maxillofacial and oral surgery · 2024
    Article
  2. Review
  3. Notch as a Possible Cell Differentiation Factor in Pleomorphic Adenomas.International journal of medical sciences · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yukiko Okuda1. Hard Tissue Pathology Unit, Matsumoto Dental University Graduate School of Oral Medicine, Shiojiri, Japan ; 3. Department of Oral and Maxillofacial Surgery, Hyogo Prefectural Tsukaguchi Hospital, Amagasaki, Japan.
Keisuke Nakano1. Hard Tissue Pathology Unit, Matsumoto Dental University Graduate School of Oral Medicine, Shiojiri, Japan ; 4. Department of Oral Pathology, Matsumoto Dental University School of Dentistry, Shiojiri, Japan.
Koji Suzuki2. Department of Oral Pathology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
Yoshihiko Sugita2. Department of Oral Pathology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan ; 5. Center for Advanced Oral Science, Aichi Gakuin University, Nagoya, Japan.
Katsutoshi Kubo2. Department of Oral Pathology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan ; 5. Center for Advanced Oral Science, Aichi Gakuin University, Nagoya, Japan.
Hatsuhiko Maeda2. Department of Oral Pathology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan ; 5. Center for Advanced Oral Science, Aichi Gakuin University, Nagoya, Japan.
Norimasa Okafuji6. Clinical Evaluation Unit, Matsumoto Dental University Graduate School of Oral Medicine, Shiojiri, Japan.
Hiromasa Hasegawa1. Hard Tissue Pathology Unit, Matsumoto Dental University Graduate School of Oral Medicine, Shiojiri, Japan ; 4. Department of Oral Pathology, Matsumoto Dental University School of Dentistry, Shiojiri, Japan.
Toshiyuki Kawakami1. Hard Tissue Pathology Unit, Matsumoto Dental University Graduate School of Oral Medicine, Shiojiri, Japan.
Matsumoto Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are well known that Wnt signaling was some roles of cell differentiation at the development tissues, especially the oral and maxillofacial regions of some developmental stages. Therefore, to determine Wnt signaling in the pleomorphic adenoma tissues, we examined. The expression of Wnt1 and β-catenin as well as the distribution of various cytoskeletal proteins CK7 and CK13 was examined in 30 cases of pleomorphic adenoma by immunohistochemistry. Wnt1 was detected in almost all tumor cells. The peripheral columnar cells in squamous metaplasia and small cuboidal cells in duct-like structures were strongly positive to Wnt1. Although β-catenin was clearly localized on the cell membrane of tumor cells, nuclear translocation was observed in small cuboidal cells and in some basaloid cells. The immunofluorescent staining pattern of Wnt1 and CK7 as well as Wnt1 and CK13 was consistent with IHC results. Thus, in pleomorphic adenoma, Wnt is involved in tumor cell differentiation of peripheral columnar cells forming solid nests and small peripheral columnar cells forming duct-like structures. Moreover, among the three currently known Wnt pathways, β-catenin is the suggested pathway working during cell differentiation. Furthermore, peripheral columnar cells in solid tumor nests and in squamous metaplasia are governed by another Wnt pathway other than β-catenin. Therefore, Wnt signaling through β-catenin pathway may be involved in the 'mixed' differentiation characteristic of pleomorphic adenoma although another pathway may also be possibly working in other parts of the tumor tissue.

Indexed as

Adenoma, Pleomorphicbeta CateninCell DifferentiationEpithelial CellsFemaleGene Expression Regulation, NeoplasticHumansImmunohistochemistryKeratinsMaleMiddle AgedWnt1 ProteinWnt Signaling Pathwaybeta CateninKeratinsWnt1 ProteinWNT1 protein, humancell differentiationcytokeratinimmunohistochemistrypleomorphic adenomaWnt signalingβ-catenin

Identifiers

PMID25076852
PMCPMC4113590
OpenAlexW2018235077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.